| Impure Science |
| Acknowledgments |
| Introduction Controversy, Credibility, and the Public Character of Aids Research |
| The Crisis of Credibility and the Rise of the AIDS Movement |
| • | The Politics of Trust and Distrust |
| • | The Distinctive Character of the AIDS Movement |
| Analyzing AIDS Controversies |
| • | Credibility and Trust in Scientific Fact-Making |
| • | Science Studies and the Problem of Knowledge-Making from Below |
| • | Science Studies and Social Movement Research |
| • | The Media and the Construction of Credibility |
| • | Medicine and the Professions |
| • | Constructing Social Reality |
| The Plan of the Book |
| • | Part One: The Politics of Causation |
| Part Two: The Politics of Treatment |
| • | The Conduct of Clinical Research. |
| • | The Interpretation of Studies. |
| • | The Politics of Risk and Regulation. |
| • | Conceptualizing Aids: Some Intellectual Debts |
| Part 1 The Politics of Causation |
| Chapter 1 The Nature of a New Threat |
| The Discovery of a "Gay Disease" (1981-1982) |
| • | First Reports |
| • | The Politics of Lifestyle |
| • | Claiming the Epidemic |
| Lifestyle vs. Virus (1982–1983) |
| • | The Expansion of Risk |
| • | Germs and Magic Bullets |
| • | Dissent at the Front Lines |
| • | Medical Uncertainty and Gay Skepticism |
| The Triumph of Retrovirology (1982–1984) |
| • | Gallo's Family of Viruses |
| • | The French Virus |
| • | An Addition to the Honor Roll? |
| • | "Strong Evidence of a Causative Involvement" |
| • | Koch's Postulates and the Proof of Causation |
| • | The Framing of AIDS |
| Chapter 2 HIV and the Consolidation of Certainty |
| The Construction of Scientific Proof (1984–1986) |
| • | The Blossoming of AIDS Research |
| • | Citation and the Construction of Facts |
| • | Blood and Chimps |
| HIV as "Obligatory Passage Point" |
| • | The Power of a Hypothesis |
| • | Science, the Media, and the Construction of Social Reality |
| • | The Appeal of a Virus |
| • | Alternative Viewpoints |
| • | Markers of Credibility |
| Chapter 3 Reopening The Causation Controversy |
| From Deafening Silence to the Pages of Science (1987–1988) |
| • | Posing the Challenge |
| • | A Controversy Takes Public Shape |
| • | Interests, Investments, and "Fallen Angels" |
| • | The Duesberg Story Goes Mainstream |
| • | Gay Despair, Gay Suspicion |
| • | The Establishment Hits Back |
| • | Amassing Credibility |
| • | The Consequences of Controversy |
| Consolidation and Refinement (1989–1991) |
| • | "Red Flags" at the Academy |
| • | Arenas of Controversy |
| • | The Heritage Foundation and the "Risk-Aids Hypothesis" |
| • | "The Impact of the Truck" |
| • | From Outside to Inside and Back Again |
| Chapter 4 The Debate That Wouldn't Die |
| The Controversy Reignites (1991–1992) |
| • | From Isolation to Organization |
| • | The "Drug-Aids Hypothesis" |
| • | The HIV Heretics and the "Murdoch Press" |
| • | Mavericks and High-Flyers |
| • | Gathering of the Tribes |
| • | Project Inform Stakes its Claims |
| • | Left and Right |
| • | The "Vietnam Syndrome" |
| • | "AIDS Without HIV" |
| The Dynamics of Closure: Whither the Controversy? (1992–1995) |
| • | The Definitive Study? |
| • | The Terms of the Debate |
| Causation and Credibility |
| • | Credibility Tactics |
| • | Mainstream and Alternative Media |
| • | Democracy as Rhetoric and Reality |
| • | From Causation to Treatment |
| Part 2 The Politics of Treatment |
| Chapter 5 Points of Departure |
| Targeting a Retrovirus (1984–1986) |
| • | The Logic of Treatment |
| • | The Genesis of Treatment Activism |
| • | Rights, Risks, and Ethics |
| • | The State of the Art, 1985 |
| • | "Waiting for the Right Disease" |
| Clinical Trials Take Center Stage (1986–1987) |
| • | Becoming Experts |
| • | The Gold Standard |
| • | "Great Promise for Prolonging Life" |
| • | The Politics of "Indifference" |
| • | Placebos Under Attack |
| • | The Repudiation of Victimhood |
| Chapter 6 "Drugs Into Bodies" |
| Gaining Access (1987–1988) |
| • | "It's Not That Easy" |
| • | Sacrificial Lambs |
| • | Dual Roles and "Double Agents" |
| A Knowledge-Empowered Movement |
| • | A Lab of One's Own |
| • | Acting Up |
| • | The Discourse of Genocide |
| • | The FDA under Fire |
| • | Beyond the FDA |
| • | Learning New Languages |
| • | The "Impurities" of Activism |
| Chapter 7 The Critique of Pure Science |
| AZT and the Politics of Interpretation (1989–1990) |
| • | Signs of Rapprochement |
| • | AZT: "The Time Has Come" |
| • | Poison? Or Just Mediocre? |
| • | Two Committees, Two Conclusions |
| Activism and the Manufacture of Knowledge (1989–1991) |
| • | Methodology to the Rescue |
| • | The Questions of Real Importance |
| • | Credibility and Representation |
| • | Access, Heterogeneity, and Pragmatism |
| • | The Politics of Purity |
| • | Heterogeneity and Social Difference |
| • | Old Dogs and New Tricks |
| Chapter 8 Dilemmas and Divisions in Science and Politics |
| Combination Therapy and the "Surrogate Markers" Debate (1989–1992) |
| • | The Origins of a Bandwagon |
| • | Surrogate Markers to the Rescue |
| • | The "Future that we all Envisioned" |
| • | Between "Science" and "Policy" |
| • | The Genie in the Bottle |
| Inside and Outside the System |
| • | New Antiviral Research and the "Receding" Bottleneck |
| • | A Seat at the Table |
| • | The Reconstitution of Identity |
| • | The Diversification of Treatment Activism |
| • | The Politics of Cleavage |
| Chapter 9 Clinical Trials and Tribulations |
| The Search for New Directions (1992–1993) |
| • | "Outsmarting Science" |
| • | A "New Paradigm" for Treatment Activism |
| • | The Science of "Concordology" |
| • | Berlin |
| • | Doctors, Researchers, and "Cookbook Medicine" |
| Living with Uncertainty (1993–1995) |
| • | AZT: More "Pieces of the Elephant" |
| • | The Holy Grail of Statistics |
| • | East Coast, West Coast |
| • | Back to Basics |
| • | "Cocktails" and "Synergy" |
| • | Promoting "Good Science" |
| Conclusion Credible Knowledge Hierarchies of Expertise, and the Politics of Participation in Biomedicine |
| Science and the Struggle for Credibility |
| • | The Boundaries of Impure Science |
| • | Credibility and the Management of Uncertainty |
| • | Pathways to Credibility |
| The Transformation of AIDS Research |
| • | Credit Where Credit is Due |
| • | The Politics of Access |
| • | "Situated Knowledges" and the Lure of Science |
| • | Trials and Truth-Making |
| The Legacy of AIDS Activism |
| • | The Refashioning of Patients and Doctors |
| • | New Voices on the Medical Horizon |
| • | Expertise and Democracy |
| Notes |
| • | Introduction Controversy, Credibility, and the Public Character of Aids Research |
| • | Chapter 1 The Nature of a New Threat |
| • | Chapter 2 HIV and the Consolidation of Certainty |
| • | Chapter 3 Reopening The Causation Controversy |
| • | Chapter 4 The Debate That Wouldn't Die |
| • | Chapter 5 Points of Departure |
| • | Chapter 6 "Drugs Into Bodies" |
| • | Chapter 7 The Critique of Pure Science |
| • | Chapter 8 Dilemmas and Divisions in Science and Politics |
| • | Chapter 9 Clinical Trials and Tribulations |
| • | Conclusion Credible Knowledge Hierarchies of Expertise, and the Politics of Participation in Biomedicine |
| • | Methodological Appendix |
| Methodological Appendix |
| • | Sources |
| • | Symmetry and the Study of Scientific Controversies |
| • | Archeology and Genealogy |
| Content Analysis |
| • | Scientific Journal Articles |
| • | New York Times Articles |
| Index |
| • | A |
| • | B |
| • | C |
| • | D |
| • | E |
| • | F |
| • | G |
| • | H |
| • | I |
| • | J |
| • | K |
| • | L |
| • | M |
| • | N |
| • | O |
| • | P |
| • | Q |
| • | R |
| • | S |
| • | T |
| • | U |
| • | V |
| • | W |
| • | Y |
| • | Z |